DK164019C - Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf - Google Patents

Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK164019C
DK164019C DK434784A DK434784A DK164019C DK 164019 C DK164019 C DK 164019C DK 434784 A DK434784 A DK 434784A DK 434784 A DK434784 A DK 434784A DK 164019 C DK164019 C DK 164019C
Authority
DK
Denmark
Prior art keywords
protrahered
procedures
effects
production
pharmaceutical composition
Prior art date
Application number
DK434784A
Other languages
Danish (da)
English (en)
Other versions
DK434784A (da
DK164019B (da
DK434784D0 (da
Inventor
Jerry L Sheumaker
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of DK434784D0 publication Critical patent/DK434784D0/da
Publication of DK434784A publication Critical patent/DK434784A/da
Publication of DK164019B publication Critical patent/DK164019B/da
Application granted granted Critical
Publication of DK164019C publication Critical patent/DK164019C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK434784A 1983-09-16 1984-09-12 Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf DK164019C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53286483A 1983-09-16 1983-09-16
US53286483 1983-09-16

Publications (4)

Publication Number Publication Date
DK434784D0 DK434784D0 (da) 1984-09-12
DK434784A DK434784A (da) 1985-03-17
DK164019B DK164019B (da) 1992-05-04
DK164019C true DK164019C (da) 1992-09-28

Family

ID=24123487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434784A DK164019C (da) 1983-09-16 1984-09-12 Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf

Country Status (16)

Country Link
EP (1) EP0139881B1 (fr)
JP (1) JPH0688901B2 (fr)
KR (1) KR910003557B1 (fr)
AT (1) ATE42894T1 (fr)
AU (1) AU565487B2 (fr)
CA (1) CA1221632A (fr)
DE (1) DE3478085D1 (fr)
DK (1) DK164019C (fr)
FI (1) FI843609L (fr)
IE (1) IE57445B1 (fr)
IL (1) IL71886A (fr)
MX (1) MX171030B (fr)
NO (1) NO843673L (fr)
NZ (1) NZ208155A (fr)
PH (1) PH20237A (fr)
ZA (1) ZA844023B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
CA1331563C (fr) * 1987-08-03 1994-08-23 Gaylen M. Zentner Systeme de liberation controlee de medicaments avec modulation de type donnan par des resines chargees insolubles
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
SE9103110D0 (sv) 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
GB2360894B (en) * 2000-03-30 2004-11-10 Peter Thomas Bosson Display device support system
CA2689101C (fr) * 2007-05-30 2013-01-22 Neos Therapeutics, Lp Modification de liberation de medicament dans des suspensions de systemes de resine ioniques
WO2013088271A1 (fr) 2011-12-14 2013-06-20 Wockhardt Limited Composition pharmaceutique liquide à libération modifiée comprenant de la bromophéniramine, de la pseudoéphédrine et du dextrométhorphan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
FR5227M (fr) * 1966-03-18 1967-08-14
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations

Also Published As

Publication number Publication date
AU565487B2 (en) 1987-09-17
DK434784A (da) 1985-03-17
EP0139881B1 (fr) 1989-05-10
DE3478085D1 (en) 1989-06-15
EP0139881A1 (fr) 1985-05-08
IE57445B1 (en) 1992-09-09
FI843609A7 (fi) 1985-03-17
AU2789184A (en) 1985-03-21
IE841201L (en) 1985-03-16
IL71886A (en) 1987-11-30
DK164019B (da) 1992-05-04
FI843609L (fi) 1985-03-17
ZA844023B (en) 1985-03-27
JPH0688901B2 (ja) 1994-11-09
NO843673L (no) 1985-03-18
IL71886A0 (en) 1984-09-30
NZ208155A (en) 1987-09-30
KR850002399A (ko) 1985-05-13
MX171030B (es) 1993-09-27
CA1221632A (fr) 1987-05-12
KR910003557B1 (ko) 1991-06-05
PH20237A (en) 1986-11-10
JPS6067418A (ja) 1985-04-17
ATE42894T1 (de) 1989-05-15
FI843609A0 (fi) 1984-09-14
DK434784D0 (da) 1984-09-12

Similar Documents

Publication Publication Date Title
IL90052A (en) :-substituted 4-(quinolin- 2-yl-methoxy) phenylacetic acids and esters, their preparation and pharmaceutical compositions containing them
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
DE69022876D1 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
NL187892B (nl) Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat, dat een dihydroergotoxine bevat, alsmede inrichting voor het via de neus toedienen van een farmaceutisch preparaat.
NO932875D0 (no) Preparater i form av faste partikler som inneholder virksomme substanser, fremgangsmaate for fremstilling, samt anvendelse
AU590780B2 (en) System and method for delivering insoluble material into a living body
DE3765243D1 (de) Ibuprofen und codein enthaltende, stabile, feste arzneimittel.
DK219387D0 (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK164019C (da) Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf
DK314887D0 (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
EP0208519A3 (fr) Composition solubilisée d'un agent pharmaceutique peu soluble
SE8300320L (sv) Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
IL95444A0 (en) (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents,their preparation and pharmaceutical compositions containing them
ATE140592T1 (de) Nährstoff- und arzneimittelzubereitungen auf der basis von chitosan für die verabreichung an wiederkäuer
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DE3662822D1 (en) Calibration liquid for ion-specific electrodes, process for preparing them and their application
JO1148B1 (en) Pharmaceutical formulations
DK501385D0 (da) 1,3,4-thiadiazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
DK86488D0 (da) Monobasisk phosphatsalt af dobutamin, fremgangsmaade til fremstilling af et saadant salt samt farmaceutisk praeparat indeholdende saltet
Ford et al. Psychologists in substance-abuse: Alcoholism and drug-abuse treatment units.
GB1222294A (en) Oxazinobenzodiazepine derivatives
GB1469208A (en) Diphenylpyraline salt
TH2148A (th) สูตรผสมยาน้ำประเภทที่ปล่อยยาเนิ่นนาน ซึ่งมีส่วนผสมชนิดไอออนิคอยู่ด้วย

Legal Events

Date Code Title Description
PUP Patent expired